Diverse Hematological Malignancies Including Hodgkin-Like Lymphomas Develop in Chimeric MHC Class II Transgenic Mice

Silke H. Raffegerst, Gabriele Hoelzlwimmer, Sandra Kunder et al. · 2009

Read Diverse Hematological Malignancies Including Hodgkin-Like Lymphomas Develop in Chimeric MHC Class II Transgenic Mice by Silke H. Raffegerst, Gabriele Hoelzlwimmer, Sandra Kunder et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008539.txt.

Description

Silke Raffegerst and co-authors report blood cancers in transgenic mice in a 2009 PLOS ONE paper. Their mice carry a chimeric MHC class II gene called DR4. MHC molecules present antigen fragments to immune cells. The homozygous mouse line spontaneously develops diverse hematological malignancies. That happens at a high frequency of about seventy percent. Tumors split evenly between T cell and B cell types.

The malignancies include lymphoblastic T cell lymphomas and Hodgkin-like lymphomas. Such variety in one mouse line is unusual. The model may reveal how a single immune gene change unleashes many cancer types. It offers a system for testing treatments across blood cancers.

Catalog record

CREATORSilke H. Raffegerst, Gabriele Hoelzlwimmer, Sandra Kunder et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE51 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008539

Browse the full library · About the Tower of Babel